About Quest
Purpose
Innovations in the infectious diseases segment have historically suffered from de-prioritization in terms of investments. The Quest has been an attempt of IHF to scout and support innovations for infectious diseases since 2017. This year IHF, BCKICF and KIIT-TBI are jointly launching QUEST 2022 with the intent of finding novel solutions to some of the most pressing problems affecting the control, care, and cure of infectious diseases. Read more
A Joint Initiative By:
Focus Areas
Screening and Diagnosis
Solutions that are point of care, portable, rapid, accurate, and easily interfaced with health systems
Care Pathways
Proven technologies that can improve the care continuum and ensure availability and accessibility of healthcare at primary levels
Disease Surveillance
Innovations to support disease surveillance to effectively strengthen the health systems for responsive, timely and appropriate actions for control of disease outbreaks
Quest 2022
Program Document
Please refer to the program document to get a holistic understanding of Quest 2022.
Program Offerings
Funding Support
Milestone-based funding support
Product Validation
Support with building linkages for evidence generation with relevant public, private, academic and research institutions
Mentoring
Need-based mentoring by a panel of experts
Market Access
Access to resources for adoption in the health system and acceleration
Evaluation Criteria
Novelty
Uniqueness of the idea/technology/solution
Impact
Demonstrated/potential ability of the innovations to impact health outcomes upto primary care level
Multi-disease Potential
Ability of the innovation to be adapted to multiple disease areas
Scalability
Competitiveness on quality, cost, timeliness, and service levels to ensure adoption
Sustainability
An underlying business model/value proposition for sustainable impact
Eligibility
- Applications must be submitted by entities registered and incorporated in India.
- The proposal should be relevant and aligned to at least one of the focus areas.
- The innovation should have completed the proof-of-concept and pre-clinical validation stage.
- Applicants must submit validation data for justifying support for the next stage.
- Transparency in furnishing relevant data in support of the proposed innovation should be agreeable to the applicants.
- The innovation should be TRL- 5 and above (See FAQ for an explanation of TRL)
- Promising proposals at TRL 5, 6 & 7 will be supported for product development, clinical validation, regulatory approvals, and multicentric trials
- Promising innovations at TRL 8 & 9 will be supported for evidence demonstration, community validation and acceleration.
Timelines
Contact Us
For any queries, applicants can write to [email protected] / [email protected]
FAQs
No, you cannot edit your application after you have submitted.
Yes, you can submit multiple applications within the above focus areas and evaluation criteria as mentioned. Please note that each application is associated with one email address. Therefore, please use different email addresses if you are making more than one application.